TY - JOUR
T1 - Viral capsid mobility
T2 - A dynamic conduit for inactivation
AU - Broo, Klas
AU - Wei, Jing
AU - Marshall, Dawn
AU - Brown, Fred
AU - Smith, Thomas J.
AU - Johnson, John E.
AU - Schneemann, Anette
AU - Siuzdak, Gary
PY - 2001/2/27
Y1 - 2001/2/27
N2 - Mass spectrometry and fluorescent probes have provided direct evidence that alkylating agents permeate the protein capsid of naked viruses and chemically inactivate the nucleic acid. N-acetylaziridine and a fluorescent alkylating agent, dansyl sulfonate aziridine, inactivated three different viruses, flock house virus, human rhinovirus-14, and foot and mouth disease virus. Mass spectral studies as well as fluorescent probes showed that alkylation of the genome was the mechanism of inactivation. Because particle integrity was not affected by selective alkylation (as shown by electron microscopy and sucrose gradient experiments), it was reasoned that the dynamic nature of the viral capsid acts as a conduit to the interior of the particle. Potential applications include fluorescent labeling for imaging viral genomes in living cells, the sterilization of blood products, vaccine development, and viral inactivation in vivo.
AB - Mass spectrometry and fluorescent probes have provided direct evidence that alkylating agents permeate the protein capsid of naked viruses and chemically inactivate the nucleic acid. N-acetylaziridine and a fluorescent alkylating agent, dansyl sulfonate aziridine, inactivated three different viruses, flock house virus, human rhinovirus-14, and foot and mouth disease virus. Mass spectral studies as well as fluorescent probes showed that alkylation of the genome was the mechanism of inactivation. Because particle integrity was not affected by selective alkylation (as shown by electron microscopy and sucrose gradient experiments), it was reasoned that the dynamic nature of the viral capsid acts as a conduit to the interior of the particle. Potential applications include fluorescent labeling for imaging viral genomes in living cells, the sterilization of blood products, vaccine development, and viral inactivation in vivo.
UR - http://www.scopus.com/inward/record.url?scp=0035956946&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035956946&partnerID=8YFLogxK
U2 - 10.1073/pnas.051598298
DO - 10.1073/pnas.051598298
M3 - Article
C2 - 11226229
AN - SCOPUS:0035956946
SN - 0027-8424
VL - 98
SP - 2274
EP - 2277
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 5
ER -